Lymphoma Leukemia

3 registered clinical trials studyying Lymphoma Leukemia.

Status	Trial	Sponsor	Phase
Withdrawn	Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL NCT05114837	Masonic Cancer Center, University of Minnesota	Phase 1 / Phase 2
Unknown	To Study the Concentration Level of, Doxil, and Doxorubicin at Various Time Frames NCT03975205	Sutphin Drugs	EARLY_Phase 1
Completed	Immunotherapy With CD19 CAR T-cells in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma NCT03811457	UWELL Biopharma	N/A